Exact Sciences expanding cancer diagnostics capabilities with $190M acquisition

Exact Sciences
Exact Sciences

Exact Sciences says the $190 million acquisition of Marshfield-based PreventionGenetics will expand its cancer diagnostics capabilities. 

The move also sets up the Madison company’s entrance into the field of hereditary cancer testing, which focuses on detecting heritable genetic mutations that could increase the risk of developing certain cancers. 

"With our deep relationships in primary care and PreventionGenetics' strong reputation among genetics specialists, Exact Sciences can help more people understand their inherited risk of cancer to catch it earlier and treat it more effecti...

Please log in to access subscriber content.
If you don't have a subscription, click here for a WisPolitics free trial and to view the different subscription options.
Facebook
Twitter
LinkedIn

Upcoming Events